95 related articles for article (PubMed ID: 6429990)
1. Effects of chronic luteinizing hormone-releasing hormone agonist treatment on dysfunctional uterine bleeding in the stumptailed macaque.
Fraser HM; Shaw RW
Acta Endocrinol (Copenh); 1984 Jul; 106(3):381-6. PubMed ID: 6429990
[TBL] [Abstract][Full Text] [Related]
2. Effects of chronic LHRH agonist treatment on the endometrium and ovaries of the stumptailed macaque.
Kerr-Wilson RH; MacKenzie L; Fraser HM
Contraception; 1981 Dec; 24(6):647-55. PubMed ID: 6799243
[TBL] [Abstract][Full Text] [Related]
3. An implant of a gonadotropin releasing hormone agonist (buserelin) which suppresses ovarian function in the macaque for 3-5 months.
Fraser HM; Sandow J; Seidel H; von Rechenberg W
Acta Endocrinol (Copenh); 1987 Aug; 115(4):521-7. PubMed ID: 3115020
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of ovulation during discontinuous intranasal luteinizing hormone-releasing hormone agonist dosing in combination with gestagen-induced bleeding.
Lemay A; Faure N; Labrie F; Fazekas AT
Fertil Steril; 1985 Jun; 43(6):868-77. PubMed ID: 3158551
[TBL] [Abstract][Full Text] [Related]
5. Effect of treatment for 1 year with a luteinizing hormone-releasing hormone agonist on ovarian, thyroidal, and adrenal function and menstruation in the stumptailed monkey (Macaca arctoides).
Fraser HM
Endocrinology; 1983 Jan; 112(1):245-53. PubMed ID: 6401177
[No Abstract] [Full Text] [Related]
6. Inhibition of folliculogenesis in the monkey following early follicular phase administration of an LRH agonist.
Wilks JW
Acta Endocrinol (Copenh); 1984 Aug; 106(4):538-43. PubMed ID: 6433613
[TBL] [Abstract][Full Text] [Related]
7. Suppression of follicular maturation by infusion of a luteinizing hormone-releasing hormone agonist starting during the late luteal phase in the stumptailed macaque monkey.
Fraser HM; Sandow J
J Clin Endocrinol Metab; 1985 Mar; 60(3):579-84. PubMed ID: 3919049
[TBL] [Abstract][Full Text] [Related]
8. Suppression of luteal function by a luteinizing hormone-releasing hormone antagonist during the early luteal phase in the stumptailed macaque monkey and the effects of subsequent administration of human chorionic gonadotropin.
Fraser HM; Nestor JJ; Vickery BH
Endocrinology; 1987 Aug; 121(2):612-8. PubMed ID: 3109885
[TBL] [Abstract][Full Text] [Related]
9. [Progress in the contraceptive use of the LH-RH agonist buserelin: intermittent medication with gestagen-induced withdrawal bleeding].
Hardt W; Schmidt-Gollwitzer K; Nevinny-Stickel J; Schmidt-Gollwitzer M
Geburtshilfe Frauenheilkd; 1982 Dec; 42(12):874-7. PubMed ID: 6819180
[TBL] [Abstract][Full Text] [Related]
10. Peptide contraception in women. Inhibition of ovulation by chronic intranasal LRH agonist therapy.
Bergquist C; Nillius SJ; Wide L
Ups J Med Sci; 1984; 89(2):99-106. PubMed ID: 6431676
[TBL] [Abstract][Full Text] [Related]
11. Endometrial patterns in women on chronic luteinizing hormone-releasing hormone agonist treatment for contraception.
Bergquist C; Nillius SJ; Wide L; Lindgren A
Fertil Steril; 1981 Sep; 36(3):339-42. PubMed ID: 6793403
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of progesterone secretion during the luteal phase by two luteinizing hormone-releasing hormone agonists in Macaca fascicularis.
Raynaud JP; Mary I; Moguilewsky M; Mouren M; Labrie F
Fertil Steril; 1980 Dec; 34(6):593-8. PubMed ID: 6778718
[TBL] [Abstract][Full Text] [Related]
13. Fourteen-day versus twenty-one-day regimens of intermittent intranasal luteinizing hormone-releasing hormone agonist combined with an oral progestogen as antiovulatory contraceptive approach.
Lemay A; Faure N
J Clin Endocrinol Metab; 1986 Dec; 63(6):1379-85. PubMed ID: 2946711
[TBL] [Abstract][Full Text] [Related]
14. Effect of oestrogen on gonadotrophin release in stumptailed monkeys (Macaca arctoides) treated chronically with an agonist analogue of luteinizing hormone releasing hormone.
Fraser HM
J Endocrinol; 1981 Dec; 91(3):525-30. PubMed ID: 6799604
[TBL] [Abstract][Full Text] [Related]
15. Effects of an antiprogesterone (RU486) on the hypothalamic-hypophyseal-ovarian-endometrial axis during the luteal phase of the menstrual cycle.
Garzo VG; Liu J; Ulmann A; Baulieu E; Yen SS
J Clin Endocrinol Metab; 1988 Mar; 66(3):508-17. PubMed ID: 2832438
[TBL] [Abstract][Full Text] [Related]
16. Long-term suppression of ovarian function by a luteinizing-hormone releasing hormone agonist implant in patients with endometriosis.
Fraser HM; Sandow J; Cowen GM; Lumsden MA; Haining R; Smith SK
Fertil Steril; 1990 Jan; 53(1):61-8. PubMed ID: 2104808
[TBL] [Abstract][Full Text] [Related]
17. Suppression of ovarian function with the transdermally given synthetic progestin ST 1435.
Laurikka-Routti M; Haukkamaa M; Lähteenmäki P
Fertil Steril; 1992 Oct; 58(4):680-4. PubMed ID: 1426309
[TBL] [Abstract][Full Text] [Related]
18. Endocrine characterization of the menstrual cycle of the stumptailed monkey (Macaca arctoides).
Wilks JW
Biol Reprod; 1977 May; 16(4):474-8. PubMed ID: 403966
[TBL] [Abstract][Full Text] [Related]
19. Levels of follicle-stimulating hormone, luteinizing hormone, oestradiol-17 beta and progesterone, and follicular growth in the pseudopregnant rat.
Welschen R; Osman P; Dullaart J; de Greef WJ; Uilenbroek JT; de Jong FH
J Endocrinol; 1975 Jan; 64(1):37-47. PubMed ID: 1167896
[TBL] [Abstract][Full Text] [Related]
20. Controlled release of a GnRH agonist from a polyhydroxybutyric acid implant: reversible suppression of the menstrual cycle in the macaque.
Fraser HM; Sandow J; Seidel HR; Lunn SF
Acta Endocrinol (Copenh); 1989 Dec; 121(6):841-8. PubMed ID: 2514544
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
